Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prisoners | 21 | 2024 | 179 | 3.540 |
Why?
|
| Opioid-Related Disorders | 12 | 2024 | 526 | 3.480 |
Why?
|
| Smoking Cessation | 27 | 2022 | 551 | 2.910 |
Why?
|
| Substance-Related Disorders | 19 | 2026 | 755 | 2.390 |
Why?
|
| Prisons | 16 | 2025 | 120 | 1.930 |
Why?
|
| Alcoholism | 11 | 2019 | 327 | 1.860 |
Why?
|
| Opiate Substitution Treatment | 7 | 2024 | 223 | 1.820 |
Why?
|
| Smoking | 19 | 2022 | 861 | 1.630 |
Why?
|
| Buprenorphine | 6 | 2024 | 198 | 1.630 |
Why?
|
| Motivation | 14 | 2022 | 296 | 1.180 |
Why?
|
| Narcotic Antagonists | 4 | 2024 | 133 | 0.980 |
Why?
|
| Harm Reduction | 2 | 2024 | 33 | 0.980 |
Why?
|
| Criminal Law | 2 | 2024 | 87 | 0.980 |
Why?
|
| Staff Development | 1 | 2026 | 58 | 0.920 |
Why?
|
| Varenicline | 3 | 2019 | 11 | 0.870 |
Why?
|
| Adult | 48 | 2026 | 17351 | 0.850 |
Why?
|
| Mobile Health Units | 1 | 2024 | 20 | 0.830 |
Why?
|
| Surveys and Questionnaires | 15 | 2019 | 2762 | 0.820 |
Why?
|
| Leadership | 1 | 2026 | 211 | 0.810 |
Why?
|
| Health Personnel | 2 | 2026 | 385 | 0.800 |
Why?
|
| Public Health | 2 | 2024 | 186 | 0.790 |
Why?
|
| Vaccination | 1 | 2025 | 375 | 0.760 |
Why?
|
| Smoking Prevention | 7 | 2017 | 163 | 0.760 |
Why?
|
| Tobacco Products | 2 | 2022 | 63 | 0.730 |
Why?
|
| Juvenile Delinquency | 3 | 2019 | 56 | 0.700 |
Why?
|
| Residential Treatment | 6 | 2022 | 34 | 0.690 |
Why?
|
| Male | 55 | 2026 | 31014 | 0.680 |
Why?
|
| Tobacco Use Disorder | 8 | 2019 | 246 | 0.670 |
Why?
|
| Rhode Island | 8 | 2024 | 110 | 0.660 |
Why?
|
| Psychometrics | 8 | 2019 | 392 | 0.650 |
Why?
|
| Humans | 69 | 2026 | 65095 | 0.650 |
Why?
|
| Female | 53 | 2026 | 33997 | 0.630 |
Why?
|
| Medication Adherence | 2 | 2019 | 199 | 0.630 |
Why?
|
| Cocaine-Related Disorders | 7 | 2010 | 81 | 0.620 |
Why?
|
| Substance Abuse Treatment Centers | 9 | 2019 | 104 | 0.620 |
Why?
|
| Psychotherapy, Group | 2 | 2016 | 34 | 0.570 |
Why?
|
| Drug Monitoring | 2 | 2019 | 202 | 0.560 |
Why?
|
| Adaptation, Psychological | 5 | 2015 | 282 | 0.540 |
Why?
|
| Motivational Interviewing | 6 | 2016 | 49 | 0.530 |
Why?
|
| Temperance | 3 | 2015 | 13 | 0.500 |
Why?
|
| Adolescent Behavior | 2 | 2015 | 194 | 0.490 |
Why?
|
| Attitude to Health | 2 | 2016 | 296 | 0.450 |
Why?
|
| Religion and Psychology | 1 | 2015 | 11 | 0.450 |
Why?
|
| Patient Compliance | 3 | 2017 | 364 | 0.430 |
Why?
|
| Analgesics, Opioid | 5 | 2022 | 526 | 0.410 |
Why?
|
| United States | 15 | 2025 | 8093 | 0.410 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1559 | 0.400 |
Why?
|
| Reproducibility of Results | 10 | 2019 | 1698 | 0.400 |
Why?
|
| Cigarette Smoking | 3 | 2019 | 56 | 0.390 |
Why?
|
| Treatment Outcome | 16 | 2022 | 5784 | 0.390 |
Why?
|
| Middle Aged | 26 | 2025 | 18254 | 0.390 |
Why?
|
| Secondary Prevention | 4 | 2013 | 165 | 0.370 |
Why?
|
| Drug Overdose | 2 | 2024 | 122 | 0.340 |
Why?
|
| Young Adult | 15 | 2024 | 4810 | 0.330 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 2014 | 126 | 0.310 |
Why?
|
| New England | 4 | 2026 | 271 | 0.300 |
Why?
|
| Behavior, Addictive | 2 | 2026 | 75 | 0.300 |
Why?
|
| Alcohol Drinking | 2 | 2019 | 322 | 0.300 |
Why?
|
| Naltrexone | 3 | 2022 | 91 | 0.300 |
Why?
|
| Reward | 4 | 2018 | 89 | 0.280 |
Why?
|
| Self Efficacy | 3 | 2019 | 204 | 0.260 |
Why?
|
| Binge Drinking | 2 | 2019 | 38 | 0.240 |
Why?
|
| Counseling | 7 | 2018 | 375 | 0.230 |
Why?
|
| Program Development | 1 | 2026 | 208 | 0.220 |
Why?
|
| Adolescent | 10 | 2019 | 6305 | 0.220 |
Why?
|
| Urban Population | 1 | 2005 | 200 | 0.220 |
Why?
|
| Stakeholder Participation | 1 | 2024 | 29 | 0.220 |
Why?
|
| Stress, Psychological | 3 | 2016 | 476 | 0.210 |
Why?
|
| Recurrence | 4 | 2015 | 656 | 0.210 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 2482 | 0.200 |
Why?
|
| Interviews as Topic | 2 | 2024 | 530 | 0.200 |
Why?
|
| Carbon Monoxide | 3 | 2018 | 63 | 0.190 |
Why?
|
| Medicaid | 2 | 2024 | 371 | 0.190 |
Why?
|
| Self-Examination | 3 | 2008 | 5 | 0.190 |
Why?
|
| Comorbidity | 3 | 2019 | 1119 | 0.190 |
Why?
|
| Delayed-Action Preparations | 1 | 2022 | 120 | 0.180 |
Why?
|
| Smokers | 2 | 2018 | 117 | 0.160 |
Why?
|
| Qualitative Research | 1 | 2024 | 748 | 0.160 |
Why?
|
| Life Tables | 1 | 2020 | 23 | 0.160 |
Why?
|
| Underage Drinking | 1 | 2019 | 7 | 0.160 |
Why?
|
| Retrospective Studies | 2 | 2022 | 6859 | 0.150 |
Why?
|
| Substance Abuse Detection | 2 | 2018 | 39 | 0.150 |
Why?
|
| Economics, Behavioral | 1 | 2019 | 4 | 0.150 |
Why?
|
| Marijuana Abuse | 2 | 2018 | 23 | 0.150 |
Why?
|
| Telemedicine | 1 | 2024 | 363 | 0.150 |
Why?
|
| Nicotine | 2 | 2017 | 118 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 2703 | 0.140 |
Why?
|
| Sex Factors | 3 | 2017 | 991 | 0.140 |
Why?
|
| Depression | 4 | 2016 | 900 | 0.140 |
Why?
|
| Self Report | 2 | 2018 | 391 | 0.130 |
Why?
|
| Behavior Therapy | 2 | 2012 | 166 | 0.130 |
Why?
|
| Token Economy | 2 | 2014 | 7 | 0.130 |
Why?
|
| Mass Screening | 2 | 2020 | 696 | 0.130 |
Why?
|
| Craving | 1 | 2017 | 38 | 0.130 |
Why?
|
| Vaping | 1 | 2018 | 49 | 0.120 |
Why?
|
| Cotinine | 2 | 2013 | 20 | 0.120 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 801 | 0.120 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2018 | 78 | 0.120 |
Why?
|
| Tobacco Use | 1 | 2016 | 42 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 84 | 0.110 |
Why?
|
| Goals | 1 | 2016 | 96 | 0.110 |
Why?
|
| Smoke-Free Policy | 1 | 2015 | 9 | 0.110 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2015 | 55 | 0.110 |
Why?
|
| Health Status | 2 | 2016 | 447 | 0.110 |
Why?
|
| Patient Admission | 2 | 2007 | 198 | 0.110 |
Why?
|
| Impulsive Behavior | 1 | 2014 | 28 | 0.110 |
Why?
|
| Conduct Disorder | 1 | 2014 | 24 | 0.110 |
Why?
|
| Public Policy | 1 | 2014 | 38 | 0.100 |
Why?
|
| Pandemics | 3 | 2024 | 675 | 0.100 |
Why?
|
| Therapeutics | 1 | 2013 | 5 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 593 | 0.100 |
Why?
|
| Family Health | 1 | 2014 | 68 | 0.100 |
Why?
|
| Child Abuse | 1 | 2014 | 89 | 0.100 |
Why?
|
| Marijuana Smoking | 1 | 2013 | 19 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 219 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2013 | 129 | 0.090 |
Why?
|
| Anti-HIV Agents | 1 | 2013 | 139 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2015 | 317 | 0.090 |
Why?
|
| Life Style | 2 | 2012 | 321 | 0.090 |
Why?
|
| Melanoma | 2 | 2007 | 333 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2016 | 519 | 0.090 |
Why?
|
| Alcohols | 1 | 2011 | 13 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2016 | 727 | 0.080 |
Why?
|
| Patient Dropouts | 2 | 2008 | 51 | 0.080 |
Why?
|
| Risk | 1 | 2011 | 374 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 767 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2012 | 372 | 0.080 |
Why?
|
| Anxiety | 1 | 2012 | 426 | 0.070 |
Why?
|
| Interview, Psychological | 1 | 2008 | 79 | 0.070 |
Why?
|
| Body Image | 1 | 2008 | 32 | 0.070 |
Why?
|
| Drive | 1 | 2007 | 2 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2014 | 2096 | 0.070 |
Why?
|
| Ethanol | 1 | 2011 | 329 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2015 | 382 | 0.060 |
Why?
|
| Meditation | 2 | 2005 | 54 | 0.060 |
Why?
|
| Early Diagnosis | 1 | 2007 | 95 | 0.060 |
Why?
|
| Cocaine | 1 | 2007 | 101 | 0.060 |
Why?
|
| HIV Infections | 1 | 2013 | 955 | 0.060 |
Why?
|
| Aged | 6 | 2014 | 14945 | 0.060 |
Why?
|
| Overweight | 1 | 2008 | 257 | 0.060 |
Why?
|
| Personality Inventory | 1 | 2005 | 56 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2017 | 739 | 0.060 |
Why?
|
| Skin | 1 | 2008 | 422 | 0.050 |
Why?
|
| Attitude | 1 | 2005 | 101 | 0.050 |
Why?
|
| North Carolina | 1 | 2024 | 69 | 0.050 |
Why?
|
| Time Factors | 3 | 2013 | 3762 | 0.050 |
Why?
|
| Relaxation Therapy | 2 | 2015 | 25 | 0.050 |
Why?
|
| Homicide | 1 | 2024 | 31 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2024 | 40 | 0.050 |
Why?
|
| Cause of Death | 1 | 2024 | 221 | 0.050 |
Why?
|
| Mortality | 1 | 2024 | 161 | 0.050 |
Why?
|
| Alcohol-Related Disorders | 1 | 2003 | 37 | 0.050 |
Why?
|
| Suicide | 1 | 2024 | 146 | 0.050 |
Why?
|
| Principal Component Analysis | 3 | 2008 | 65 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2014 | 754 | 0.040 |
Why?
|
| Social Stigma | 1 | 2021 | 78 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 5606 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2020 | 98 | 0.040 |
Why?
|
| Cues | 2 | 2012 | 79 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 101 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 930 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 2618 | 0.030 |
Why?
|
| Breath Tests | 1 | 2018 | 14 | 0.030 |
Why?
|
| Tobacco Smoking | 1 | 2018 | 19 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 37 | 0.030 |
Why?
|
| Methadone | 1 | 2018 | 140 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 31 | 0.030 |
Why?
|
| Nicotinic Agonists | 1 | 2017 | 39 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 5422 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 21 | 0.030 |
Why?
|
| Child Health | 1 | 2015 | 33 | 0.030 |
Why?
|
| Psychotherapy, Brief | 1 | 2014 | 17 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2015 | 159 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2014 | 29 | 0.030 |
Why?
|
| Homosexuality, Female | 1 | 2014 | 22 | 0.030 |
Why?
|
| Exercise | 2 | 2016 | 962 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 1015 | 0.030 |
Why?
|
| Chest Pain | 1 | 2015 | 85 | 0.030 |
Why?
|
| Fatigue | 1 | 2015 | 113 | 0.030 |
Why?
|
| Dyspnea | 1 | 2015 | 120 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 1392 | 0.030 |
Why?
|
| Sample Size | 1 | 2013 | 67 | 0.020 |
Why?
|
| Habits | 1 | 2013 | 21 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2014 | 201 | 0.020 |
Why?
|
| Personal Autonomy | 1 | 2013 | 71 | 0.020 |
Why?
|
| Professional-Patient Relations | 1 | 2014 | 126 | 0.020 |
Why?
|
| Cough | 1 | 2015 | 183 | 0.020 |
Why?
|
| Breath Holding | 1 | 2012 | 7 | 0.020 |
Why?
|
| Intention | 1 | 2013 | 73 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 94 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2012 | 50 | 0.020 |
Why?
|
| Women's Health | 1 | 2015 | 374 | 0.020 |
Why?
|
| Health Behavior | 1 | 2015 | 484 | 0.020 |
Why?
|
| Patient Education as Topic | 2 | 2005 | 481 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 741 | 0.020 |
Why?
|
| Social Support | 1 | 2013 | 391 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1585 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 460 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1270 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1280 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 804 | 0.020 |
Why?
|
| Research Design | 1 | 2011 | 588 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2374 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 195 | 0.020 |
Why?
|
| Communication | 1 | 2012 | 596 | 0.020 |
Why?
|
| Biomarkers | 1 | 2013 | 1477 | 0.020 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2007 | 35 | 0.020 |
Why?
|
| Social Environment | 1 | 2007 | 93 | 0.020 |
Why?
|
| Body Weight | 1 | 2008 | 374 | 0.020 |
Why?
|
| Affect | 1 | 2007 | 132 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 3306 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 1112 | 0.010 |
Why?
|
| Child | 1 | 2015 | 4612 | 0.010 |
Why?
|
| Group Processes | 1 | 2004 | 41 | 0.010 |
Why?
|
| Cognition | 1 | 2007 | 508 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 65 | 0.010 |
Why?
|
| Obesity | 1 | 2008 | 1267 | 0.010 |
Why?
|
| Prognosis | 1 | 2004 | 1779 | 0.010 |
Why?
|